The intersection of wearable technology and women’s health — often termed “femtech” — has evolved from a niche market into one of the fastest-growing segments in digital health. According to Fortune Business Insights, the global femtech market was valued at USD 9.12 billion in 2025 and is projected to reach USD 41.14 billion by 2034, expanding at a compound annual growth rate (CAGR) of 18.37%. Within this landscape, smart rings are emerging as a uniquely compelling form factor for continuous, discreet, and clinically meaningful women’s health monitoring.
Unlike wrist-worn devices, smart rings offer superior sensor-skin contact stability during sleep — a critical window for capturing basal body temperature (BBT), heart rate variability (HRV), and respiratory patterns that underpin menstrual cycle tracking, fertility prediction, and pregnancy monitoring. For B2B buyers — whether hospital procurement teams, fertility clinic networks, or health-tech distributors — understanding the technology, clinical evidence, and OEM customization landscape is essential for making informed sourcing decisions.
Why Smart Rings Excel at Women’s Health Monitoring
The physiological parameters most relevant to women’s health — resting heart rate, heart rate variability, respiratory rate, skin temperature, and sleep architecture — require continuous, longitudinal data collection to yield actionable insights. Sporadic clinic measurements cannot capture the subtle, cyclical variations that characterize hormonal health.
Smart rings, worn on the finger, provide several technical advantages over wrist-based wearables:
- Superior Signal-to-Noise Ratio: The finger’s dense capillary network yields stronger photoplethysmography (PPG) signals than the wrist, particularly during sleep when motion artifacts are minimized. Research has consistently demonstrated that finger-based PPG sensors achieve higher signal fidelity than wrist-based alternatives.
- Stable Skin Contact: Rings maintain consistent pressure against the skin without the loosening and shifting common with wristbands during sleep. This stability is critical for nocturnal temperature trend analysis, which forms the basis of retrospective ovulation detection.
- 24/7 Wearability: The ring form factor is less intrusive than a wristband or chest strap, enabling continuous monitoring without the “device fatigue” that leads to compliance drop-off.
Basal Body Temperature and Cycle Tracking
The most established women’s health application for smart rings is temperature-based cycle tracking. After ovulation, progesterone secretion causes a measurable rise in basal body temperature of approximately 0.3°C to 0.5°C. By continuously monitoring skin temperature during sleep, smart rings can detect this biphasic temperature pattern and retrospectively confirm ovulation.
Apple integrated this approach into its Apple Watch ecosystem using wrist-temperature sensing for retrospective ovulation estimation. Oura Health, a pioneer in smart ring technology valued at over USD 2.5 billion, has developed dedicated women’s health features including cycle prediction algorithms, phase-based readiness scores, and integration with Natural Cycles — the first FDA-cleared digital contraceptive app.
The National Center for Biotechnology Information (NCBI) reports that the prevalence of menstrual cycle irregularities ranges from 5% to 35.6% among women globally. For the millions of women experiencing irregular cycles, polycystic ovary syndrome (PCOS), or perimenopausal transition, continuous temperature monitoring via smart rings offers a non-invasive, data-driven approach to understanding their hormonal patterns.
HRV, Stress, and Hormonal Health
Heart rate variability — the variation in time intervals between consecutive heartbeats — is a well-established biomarker of autonomic nervous system function. HRV fluctuates across the menstrual cycle, typically declining during the luteal phase as progesterone rises. Smart rings capable of continuous HRV monitoring can provide women with insights into how their cycle phases affect stress resilience, sleep quality, and exercise recovery.
For clinical applications, this data can help healthcare providers personalize treatment plans for conditions such as premenstrual dysphoric disorder (PMDD), perimenopausal symptom management, and fertility optimization. The integration of AI-driven analytics on top of raw biometric data represents the next frontier: moving from passive data collection to predictive, personalized health recommendations.
Market Dynamics and Growth Drivers
The investment landscape for women’s health technology has transformed dramatically. According to Femtech Insider’s 2026 investment tracking, startups in the menopause, fertility, diagnostics, and wearable monitoring categories have continued to attract significant venture capital. Midi Health raised USD 50 million in its Series C, reaching approximately USD 150 million in total funding. ONTO Health raised USD 20 million for AI-enabled fertility and longevity care.
The World Health Organization (WHO) has identified maternal and reproductive health as a global priority, and the United Nations Sustainable Development Goal 3 explicitly targets the reduction of maternal mortality and universal access to reproductive healthcare. These policy tailwinds create a favorable environment for medical device companies investing in women’s health monitoring solutions.
North America accounted for approximately 54.40% of the global femtech market in 2025, driven by high healthcare expenditure (USD 14,750 per capita according to CMS data), employer-sponsored fertility benefits, and FDA digital health pathways. Europe represented 22.09%. Asia-Pacific is the fastest-growing region, projected to expand at a 16.20% CAGR through 2035, fueled by rising smartphone penetration and government maternal health initiatives across China, India, and Southeast Asia.
The Menopause Opportunity
Menopause and longevity solutions represent the fastest-growing application segment within femtech, projected at a 17.40% CAGR through 2035. With approximately 1.1 billion women expected to be in perimenopause or postmenopause by 2025 globally, the demand for continuous, non-invasive monitoring tools is substantial. Smart rings — with their discreet form factor and continuous data collection — are particularly well-suited to serving this demographic.
Clinical Applications
Fertility Clinics and Assisted Reproduction
Fertility clinics represent a high-value institutional buyer segment for smart ring OEM solutions. Continuous biometric data collected over weeks or months provides fertility specialists with a richer dataset than single-point clinic measurements. Parameters such as sleep quality trends, HRV patterns, and resting heart rate changes can inform treatment timing, medication adjustments, and lifestyle recommendations.
Pregnancy Monitoring
Pregnancy monitoring via wearables is an emerging application with significant clinical potential. The Centers for Disease Control and Prevention (CDC) reports that approximately 700 women die annually in the United States from pregnancy-related complications, with 60% of these deaths considered preventable. Wearable-based early warning systems could contribute to reducing this toll.
Menopausal Health Management
For women experiencing vasomotor symptoms (hot flashes, night sweats), sleep disruption, and mood changes during perimenopause and menopause, smart rings can provide objective data to complement subjective symptom reporting. Temperature sensors can detect and log nocturnal hot flash events. Healthcare providers can use this data to personalize hormone replacement therapy (HRT) dosing and evaluate treatment efficacy.
OEM/ODM Customization Considerations
Sensor Configuration
For women’s health applications, the minimum viable sensor suite includes:
- High-precision PPG sensor: Multi-wavelength (green, red, infrared) for heart rate, HRV, SpO2, and respiratory rate
- Skin temperature sensor: Accuracy of ±0.1°C for reliable BBT trend detection
- 3-axis accelerometer: For sleep stage classification and activity tracking
- Optional EDA sensor: For stress and emotional response monitoring
Battery Life Requirements
OEM designs should target a minimum of 5-7 days of battery life on a single charge to minimize user friction. Ultra-low-power Bluetooth LE 5.0+ chipset selection is critical for achieving this target in the compact ring form factor.
Data Privacy and Regulatory Compliance
Women’s health data — particularly fertility and pregnancy information — is among the most sensitive personal data categories. B2B buyers must ensure their OEM partners implement:
- End-to-end encryption for all health data transmission
- GDPR-compliant data processing for European markets
- HIPAA-compliant architecture for U.S. healthcare provider deployments
- Transparent data policies with user-controlled data sharing and deletion
- On-device processing where feasible to minimize cloud exposure
Certification Support
Smart rings marketed for women’s health monitoring may fall under different regulatory classifications depending on the claims made. Geyan Technology Innovation supports CE, FCC, FDA, RoHS, and ISO 13485 certification processes, providing full documentation and testing support to help OEM partners achieve their target market certifications.
Industrial Design and Materials
Women’s health smart rings require particular attention to materials and design: hypoallergenic titanium or medical-grade stainless steel, IP68+ waterproofing, slim profile under 8mm width, extended size range from US 4 to US 13, and multiple aesthetic finish options (matte, polished, PVD coating).
Why Partner with Geyan Technology Innovation
Shenzhen Geyan Technology Innovation Co., Ltd. brings 28 years of electronics manufacturing experience and 14 years of smart wearable OEM/ODM expertise to every partnership. Our smart ring product line — including the R6, V80, and TK30 models — offers a flexible platform for women’s health monitoring customization.
Key OEM capabilities include custom sensor configuration, white-label hardware with full brand customization, companion app development, regulatory documentation support, competitive pricing, and rapid prototyping with 30-45 day turnaround from concept to engineering sample.
Conclusion
Smart rings represent a paradigm shift in women’s health monitoring — moving from episodic, clinic-based measurements to continuous, passive, data-rich tracking that spans menstrual cycles, fertility journeys, and menopausal transitions. The femtech market’s projected growth to USD 41.14 billion by 2034 signals that this is a structural transformation in how women’s health is monitored and managed.
For B2B buyers — whether you are a hospital procurement team evaluating remote patient monitoring solutions, a fertility clinic network seeking a white-label wearable, or a health-tech distributor expanding into the femtech category — now is the time to establish a strategic OEM partnership.
Contact Geyan Technology Innovation today to discuss your smart ring women’s health project.
📧 Email: jine@xdunmedical.com
📞 Phone: +86-13544254314
🌐 Website: xdunmedical.com
Disclaimer: This article is for informational purposes only. All certification references indicate support and compatibility with certification processes, not possession of certifications.